NASDAQ · Medical - Healthcare Information Services
Health Catalyst, Inc (HCAT) Stock
$1.77
+1.14%
NASDAQ: HCAT
Healthcare
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
3 Reasons to Sell HCAT and 1 Stock to Buy Instead
StockStory · Jul 15, 2026
3 Small-Cap Stocks We Think Twice About
StockStory · Jul 13, 2026
monday.com, Intuit, and Health Catalyst Stocks Trade Down, What You Need To Know
StockStory · Jul 8, 2026
3 Stocks Under $10 We’re Skeptical Of
StockStory · Jul 3, 2026
Health Catalyst, PubMatic, and PTC Stocks Trade Up, What You Need To Know
StockStory · Jul 1, 2026
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Insiders Held5.15%
Institutions Held78.11%
Institutions Float Held82.35%
Peer Comparison
About Health Catalyst, Inc
Health Catalyst, Inc is led by CEO Benjamin Albert, employs 1,500 people, headquartered in US, publicly traded since 2019.
Health Catalyst, Inc (HCAT) stock trades at $1.77 with a market capitalization of $130.79M. The stock is valued at a price-to-earnings (P/E) ratio of -0.48, price-to-book of 1.29, price-to-sales of 0.45. Over the past 52 weeks the stock has ranged between $0.95 and $3.62, and currently trades 51.1% below its 52-week high.
On profitability, Health Catalyst, Inc generates a return on equity (ROE) of -129.70%, return on capital employed of -21.55%, an operating margin of -11.58%, a net profit margin of -90.61%.